In March 2025, the company announced new designs to get a direct-to-customer supplying of its Wegovy weight loss drug. The company established a completely new pharmacy, named NovoCare, which might cost prospects $499 each month for use of the drug, less than half the expense of the drug by means of other pharmaceutical distribution networks.[53]Ry